TFE3 and renal cell carcinoma: Given the rarity of this entity in adults and limited therapeutic evidence, institutional case series remain valuable to enhance understanding of its clinicopathologic spectrum and outcomes. We conducted a retrospective case series of four adult female patients diagnosed with TFE3-rearranged RCC at a tertiary cancer center.